Cargando…

First person – Omkara Lakshmi Veeranki

First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Omkara Lakshmi Veeranki is first author on ‘ A novel patient-derived orthotopic xenograft m...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918780/
http://dx.doi.org/10.1242/dmm.043521
_version_ 1783480658853625856
collection PubMed
description First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Omkara Lakshmi Veeranki is first author on ‘ A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries’, published in DMM. Omkara Lakshmi is a postdoctoral fellow in the lab of Dr Dipen Maru at The University of Texas MD Anderson Cancer Center, Houston, TX, USA. The focus of her research is understanding key molecular targets and the alterations in gene expression that contribute to pathogenesis of gastrointestinal cancers, which could be used for developing anticancer therapeutics.
format Online
Article
Text
id pubmed-6918780
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-69187802019-12-24 First person – Omkara Lakshmi Veeranki Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Omkara Lakshmi Veeranki is first author on ‘ A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries’, published in DMM. Omkara Lakshmi is a postdoctoral fellow in the lab of Dr Dipen Maru at The University of Texas MD Anderson Cancer Center, Houston, TX, USA. The focus of her research is understanding key molecular targets and the alterations in gene expression that contribute to pathogenesis of gastrointestinal cancers, which could be used for developing anticancer therapeutics. The Company of Biologists Ltd 2019-12-17 /pmc/articles/PMC6918780/ http://dx.doi.org/10.1242/dmm.043521 Text en © 2019. Published by The Company of Biologists Ltd http://creativecommons.org/licenses/by/4.0This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle First Person
First person – Omkara Lakshmi Veeranki
title First person – Omkara Lakshmi Veeranki
title_full First person – Omkara Lakshmi Veeranki
title_fullStr First person – Omkara Lakshmi Veeranki
title_full_unstemmed First person – Omkara Lakshmi Veeranki
title_short First person – Omkara Lakshmi Veeranki
title_sort first person – omkara lakshmi veeranki
topic First Person
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918780/
http://dx.doi.org/10.1242/dmm.043521